JPS627162B2 - - Google Patents

Info

Publication number
JPS627162B2
JPS627162B2 JP4067684A JP4067684A JPS627162B2 JP S627162 B2 JPS627162 B2 JP S627162B2 JP 4067684 A JP4067684 A JP 4067684A JP 4067684 A JP4067684 A JP 4067684A JP S627162 B2 JPS627162 B2 JP S627162B2
Authority
JP
Japan
Prior art keywords
skin
effect
ester
aminobutyric acid
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4067684A
Other languages
Japanese (ja)
Other versions
JPS60184005A (en
Inventor
Tadatake Ogawa
Takashi Abe
Kyotaro Hasunuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP4067684A priority Critical patent/JPS60184005A/en
Publication of JPS60184005A publication Critical patent/JPS60184005A/en
Publication of JPS627162B2 publication Critical patent/JPS627162B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は皮膚老化防止用化粧料(皮膚の老化防
止に用いる皮膚化粧料)に関する。 更に詳しくは、皮膚老化防止効果(荒れ肌改善
効果、角質改善効果、ターンオーバー速度を早く
する効果等)の優れた皮膚化粧料に関する。 老化皮膚とは、乾燥して滑らかさのない荒れ肌
で、角質細胞剥離現象が認められる皮膚である。
そして老化皮膚はターンオーバー速度が遅く、ま
た皮膚に老化防止効果が付与、発現するとターン
オーバー速度が早くなると言われている。 本出願人は、先に、ビタミンEオロチン酸エス
テル並びにγ−アミノ酪酸系化合物は、皮膚の末
梢血管拡張作用により皮膚機能を亢進し、老化防
止効果を有することを見出し、提案した(特公昭
52−2979号および特公昭58−26726号公報)。 しかしながら、それらの効果はいずれも遅効性
で、クリームの場合は6ケ月後に、ローシヨンの
場合は3ケ月後に効果が現われるというように、
充分満足し得るものではなく、改良の余地を残し
ていた。 本発明者等はこの難点を改良せんとして鋭意研
究した結果、皮膚化粧料基剤の中に、後記のγ−
アミノ酪酸系化合物と、ビタミンEオロチン酸エ
ステルの両者を併用する場合は、両者による相乗
効果によつて優れた皮膚老化防止効果(荒れ肌改
善効果、角質改善効果に優れ、ターンオーバー速
度を早くする効果)が使用開始後1ケ月目という
極く短時間に発現し、かつ持続する速効性の皮膚
老化防止用化粧料が得られることを見出し、本発
明を完成した。すなわち、本発明は下記一般式、 (式中でR1、R2は水素原子またはメチル基であ
り、Rは水素原子またはアルキル基、アルケニル
基である) で表わされるγ−アミノ酪酸系化合物の少なくと
も一つとビタミンEオロチン酸エステルとを皮膚
化粧料基剤に配合してなる皮膚老化防止用化粧料
である。 本発明に使用する、前記一般式で示されるγ−
アミノ酪酸、N−メチル−γ−アミノ酪酸、N−
ジメチル−γ−アミノ酪酸およびそれらのメチル
エステル、エチルエステル、プロピルエステル、
ブチルエステル等は水、アルコール等に易溶で、
水性基剤への配合に適している。 またγ−アミノ酪酸、N−メチル−γ−アミノ
酪酸、N−ジメチル−γ−アミノ酪酸の2−エチ
ルヘキシルエステル、オクチルエステル、オレイ
ンエステル、ラウリルエステル、ヘキサデシルエ
ステル、ステアリンエステル等はグリコール類、
界面活性剤、油脂等と親和性が高く、油性基剤へ
の配合に適している。 本発明における、前記一般式で示されるγ−ア
ミノ酪酸系化合物の少なくとも一つの使用量(配
合量)は、組成物(化粧料)の重量に対して0.01
〜25重量%、好ましくは0.025〜2.5重量%、最も
好ましくは0.05〜1.0重量%である。 本発明の化粧料は、前記一般式のγ−アミノ酪
酸系化合物またはビタミンEオロチン酸エステル
をクリーム、乳液、ローシヨンの基剤に直接添加
するか、またはそれらの化合物を油相成分、水相
成分、アルコール等の溶剤等に溶解して配合し、
乳化、混合、分散、溶解、可溶化などの処理を行
なうことによつて調製される。化粧料中に配合さ
れた前記のγ−アミノ酪酸系化合物およびビタミ
ンEオロチン酸エステルは、安定で皮膚に吸収さ
れて末梢血管拡張作用により皮膚機能を亢進し、
肌の皺を防止し、肌理(きめ)こまかなかつしつ
とりとした皮膚にすると共に、優れた皮膚老化防
止効果(荒れ肌改善効果、角質改善効果に優れ、
ターンオーバー速度を早める効果)を相乗的にか
つ短時間に発現し、持続する等、顕著な効果を奏
し得る。 以下、実施例について説明する。 なお、実施例に示す部とは重量部を意味する。 実施例に記載の角質層のターンオーバー速度測
定方法、荒れ肌改善効果の測定試験法、角質改善
効果の測定試験法は下記の通りである。 (1) 角質層のターンオーバー速度測定方法 蛍光色素のダンシルクロライドを白色ワセリ
ン中に5重量%配合した軟膏を作り、被検者の
前腕部の皮膚に24時間閉塞貼布し、角質層にダ
ンシルクロライドを浸透結合させる。その後同
じ部位に1日2回(朝.夕)被検試料を塗布
し、毎日ダンシルクロライドの蛍光をしらべ、
その蛍光を消滅するまでの日数を皮膚角質層の
ターンオーバー速度とした。なお、通常の皮膚
角質層のターンオーバー速度は14〜16日である
が、老化した皮膚においては18日前後にのび
る。それに対して老化防止効果が現れると12日
前後にまで短縮される。 (2) 荒れ肌改善効果の測定試験法 下脚に荒れ肌を有する中高年被験者20名を対
象として4週間連続塗布効果を調べた。被験者
の左側下脚試験部位に1日2回約1gのクリー
ムを塗布し、試験開始前および終了後の皮膚の
状態を第1表の基準により判定した。右側下脚
は試料を塗布せず対照とした。 第1表 皮膚乾燥度の判定基準 −:正常 ±:軽微乾燥、落屑なし +:乾燥、落屑軽度 ++:乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を
比較し、皮膚乾燥度が2段階以上改善された場
合(例えば+→−、++→±)を「有効」、1段
階改善された場合を「やや有効」、変化がなか
つた場合を「無効」とした。尚、試験期間中に
皮膚の乾燥が進んだ例はなかつた。 (3) 角質改善(角質細胞の抗剥離性増大)効果の
測定試験法 前述の荒れ肌改善測定試験開始前および終了
後の被験部皮膚にスコツチテープ(ニチバンメ
ンデイングテープ)を接着し、これを剥離した
時テープに付着した角質細胞の状態を走査型電
子顕微鏡によつて詳細に調べ、第2表の基準に
よつて皮膚角質細胞抗剥離性を分離し、角質改
善効果を求めた。 第2表 角質改善効果(角質細胞抗剥離性増
大)の判定基準 評価点1:スケールを認めず 〃 2:小スケール点在 〃 3:小〜中スケール顕著 〃 4:大スケール顕著 第2表は4週間連続塗布後の試験部位の評価
点と対照部位のそれとの差が2点以上の場合を
「有効」、1点の場合を「やや有効」、0点の場
合を「無効」とした。 尚、試験部位の評価点が対照部位のそれより
も大きい例はなかつた。 実施例 1 (スキンミルク)
The present invention relates to cosmetics for preventing skin aging (skin cosmetics used for preventing skin aging). More specifically, the present invention relates to skin cosmetics with excellent skin aging prevention effects (improving rough skin, improving keratin, increasing turnover rate, etc.). Aging skin is dry, rough skin that lacks smoothness and exhibits a phenomenon of exfoliation of keratin cells.
It is said that aging skin has a slow turnover rate, and that when an anti-aging effect is imparted to the skin, the turnover rate becomes faster. The applicant previously discovered and proposed that vitamin E orotate ester and γ-aminobutyric acid compounds enhance skin function and have an anti-aging effect by dilating peripheral blood vessels in the skin (Tokuko Showa).
52-2979 and Special Publication No. 58-26726). However, all of these effects are slow-acting, with creams showing their effects after 6 months and lotions showing their effects after 3 months.
This was not completely satisfactory and left room for improvement. The present inventors have conducted intensive research to improve this difficulty, and as a result, the following γ-
When aminobutyric acid compounds and vitamin E orotate ester are used together, the synergistic effect of the two results in excellent skin aging prevention effects (excellent effects on improving rough skin and keratin, and speeding up turnover rate). ) has been discovered in a very short period of time, one month after the start of use, and that a long-acting cosmetic for preventing skin aging can be obtained, and the present invention has been completed. That is, the present invention has the following general formula, (In the formula, R 1 and R 2 are a hydrogen atom or a methyl group, and R is a hydrogen atom or an alkyl group or an alkenyl group.) and vitamin E orotate ester. This is a cosmetic for preventing skin aging, which is made by blending the following into a skin cosmetic base. γ- used in the present invention, represented by the above general formula
Aminobutyric acid, N-methyl-γ-aminobutyric acid, N-
Dimethyl-γ-aminobutyric acid and their methyl esters, ethyl esters, propyl esters,
Butyl esters etc. are easily soluble in water, alcohol, etc.
Suitable for formulation into aqueous bases. In addition, γ-aminobutyric acid, N-methyl-γ-aminobutyric acid, 2-ethylhexyl ester, octyl ester, oleic ester, lauryl ester, hexadecyl ester, stearin ester, etc. of N-dimethyl-γ-aminobutyric acid are glycols,
It has a high affinity with surfactants, oils and fats, and is suitable for blending into oily bases. In the present invention, the usage amount (compounding amount) of at least one of the γ-aminobutyric acid compounds represented by the above general formula is 0.01 based on the weight of the composition (cosmetic).
~25% by weight, preferably 0.025-2.5%, most preferably 0.05-1.0%. The cosmetic of the present invention can be prepared by directly adding the γ-aminobutyric acid compound or vitamin E orotate ester of the above general formula to the base of cream, emulsion, or lotion, or by adding these compounds to the oil phase component or water phase component. , dissolved in a solvent such as alcohol and blended,
It is prepared by performing treatments such as emulsification, mixing, dispersion, dissolution, and solubilization. The above-mentioned γ-aminobutyric acid compound and vitamin E orotate compounded in cosmetics are stable and absorbed into the skin, and enhance skin function by dilating peripheral blood vessels.
It prevents skin wrinkles, makes the skin smooth and moisturized, and has excellent skin aging prevention effects (excellent for improving rough skin and keratin).
The effect of accelerating the turnover rate) can be synergistically expressed and sustained in a short period of time, resulting in remarkable effects. Examples will be described below. Note that parts shown in Examples mean parts by weight. The methods for measuring the turnover rate of the stratum corneum, the test method for measuring the effect of improving rough skin, and the test method for measuring the effect of improving the stratum corneum described in the Examples are as follows. (1) Method for measuring the turnover rate of the stratum corneum An ointment containing 5% by weight of the fluorescent dye dansyl chloride in white petrolatum is made, and the ointment is applied to the skin of the subject's forearm for 24 hours, and dansyl chloride is applied to the stratum corneum. Osmotic binding of chloride. After that, the test sample was applied to the same area twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day.
The number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the stratum corneum of the skin is 14 to 16 days, but in aged skin, the turnover rate increases to around 18 days. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days. (2) Test method for measuring the effect of improving rough skin The effect of continuous application for 4 weeks was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. Approximately 1 g of cream was applied to the test site on the left lower leg of the subject twice a day, and the condition of the skin before and after the test was evaluated according to the criteria in Table 1. No sample was applied to the right lower leg, which served as a control. Table 1 Judgment criteria for skin dryness -: Normal ±: Slight dryness, no scaling +: Slight dryness, mild scaling ++: Moderate dryness, scaling +++: Dryness, significant scaling Judgment results for test and control areas before and after the test If the skin dryness has improved by two or more levels (e.g. +→-, ++→±), it is considered "effective", if it has improved by one step, it is "slightly effective", and if there is no change, it is "ineffective". And so. It should be noted that there were no cases of skin dryness progressing during the test period. (3) Test method for measuring the effect of improving keratin (increasing the anti-peeling properties of keratinocytes) Scotch tape (Nichiban Mending Tape) was adhered to the skin of the test subject before and after the above-mentioned rough skin improvement measurement test, and it was peeled off. The condition of the keratinocytes attached to the tape was examined in detail using a scanning electron microscope, and the anti-peeling properties of skin keratinocytes were determined according to the criteria shown in Table 2, and the keratin improving effect was determined. Table 2 Judgment criteria for keratin improvement effect (increased anti-desquamation property of keratinocytes) Evaluation score 1: No scale observed 〃 2: Small scale scattered 〃 3: Small to medium scale noticeable 〃 4: Large scale noticeable When the difference between the evaluation score of the test site and that of the control site after 4 weeks of continuous application was 2 points or more, it was considered "effective," when it was 1 point, "somewhat effective," and when it was 0 points, "ineffective." There were no cases in which the evaluation score of the test site was higher than that of the control site. Example 1 (skin milk)

【表】【table】

【表】 上記(第3表)処方の成分の1〜4を撹拌下に
均一に混合した後、75℃で5分間、加熱撹拌して
均一に溶融した。次にこの溶融混合物に、成分の
5〜8と成分の10を添加して均一に乳化せしめた
後、成分の9を添加し、室温まで冷却して均質な
水中油滴型エマルジヨンの各スキンミルクを調製
した。 得られた各スキンミルクについて、前記の試験
法により荒れ肌改善効果、角質改善効果、角質層
のターンオーバー速度をしらべた。その結果を第
4表に示した。
[Table] Components 1 to 4 of the above (Table 3) formulation were mixed uniformly with stirring, and then heated and stirred at 75° C. for 5 minutes to uniformly melt the mixture. Next, ingredients 5 to 8 and ingredient 10 are added to this molten mixture and homogeneously emulsified, and then ingredient 9 is added and cooled to room temperature to form a homogeneous oil-in-water emulsion. was prepared. For each of the obtained skin milks, the effect on improving rough skin, the effect on improving keratin, and the turnover rate of the stratum corneum were examined using the test methods described above. The results are shown in Table 4.

【表】 第4表の結果からも明らかなように、γ−アミ
ノ酪酸とビタミンEオロチン酸エステルを併用配
合したスキンミルクのNo.1(本発明)では、荒れ
肌改善効果、角質改善効果およびターンオーバー
速度を早くする効果が相乗的に向上し、発現して
いる。これに対して、γ−アミノ酪酸のみを配合
したスキンミルクのNo.2(比較例)、およびビタ
ミンEオロチン酸エステルのみを配合したスキン
ミルクのNo.3(比較例)では、それらの効果が本
発明のスキンミルク(No.1)よりも可成り低く、
かつスキンミルクベースのNo.4のスキンミルク
(対照例)よりはやゝ良好であるに過ぎなかつ
た。更にこれら(第3表)のスキンミルクを小じ
わの悩みを有する被検者(25才〜45才の女性)50
名に1日2回(朝、夕)、連続3ケ月間塗布、使
用せしめ、1ケ月後および3ケ月後の結果をしら
べて、後記の第5表に示した。
[Table] As is clear from the results in Table 4, skin milk No. 1 (invention) containing gamma-aminobutyric acid and vitamin E orotate ester has an effect on improving rough skin, an effect on improving keratin, and The effect of increasing the over speed is synergistically improved and manifested. On the other hand, skin milk No. 2 (comparative example) containing only γ-aminobutyric acid and skin milk No. 3 (comparative example) containing only vitamin E orotate ester showed no effect. considerably lower than the skin milk of the present invention (No. 1),
Moreover, it was only slightly better than skin milk-based skin milk No. 4 (control example). Furthermore, these skin milks (Table 3) were used by 50 subjects (women aged 25 to 45) who suffer from fine wrinkles.
The product was applied and used twice a day (morning and evening) on children for 3 consecutive months, and the results after 1 month and 3 months are shown in Table 5 below.

【表】 前記第5表の結果からも明らかなように、γ−
アミノ酪酸とビタミンEオロチン酸エステルとを
併用配合したスキンミルクのNo.1(本発明)で
は、皺(しわ)をのばす効果、きめに対する効
果、しつとり感に対する効果の何れもが使用し始
めてから1ケ月後から現われて、速効性が顕著
で、かつ持続性を有し、しかも諸効果が著しく優
れている。これに対して、γ−アミノ酪酸のみを
配合したスキンミルクのNo.2(比較例)では、し
わをのばす効果およびきめに対する効果が1ケ月
後で非常に低く、3ケ月後に若干現われるに過ぎ
ない。そして、しつとり感は1ケ月後から若干現
われるが、本発明のスキンミルクNo.1に比較する
と可成り低い。またビタミンEオロチン酸エステ
ルのみを配合したスキンミルクNo.3(比較例)
は、1ケ月後ではしわをのばす効果およびきめに
対する効果が全く無く、3ケ月後に僅かに現われ
るが、比較的低くかつ遅効性が顕著である。更に
γ−アミノ酪酸とビタミンEオロチン酸エステル
の両者を配合しないスキンミルクベース(基剤)
のスキンミルクNo.4(対照例)では、3ケ月後に
おいてもしわをのばす効果、きめに対する効果お
よびしつとり感に対する効果の何れもが殆んど認
められない。 実施例 2 (クリーム) 下記第6表に示す油相成分の所要混合物と対応
する水相成分混合物とを80℃にてそれぞれ撹拌
後、均一に油相成分中に水相成分を添加、混合し
た後、徐々に冷却して各クリーム(試料No.1〜No.
8)を調製した。
[Table] As is clear from the results in Table 5 above, γ-
Skin milk No. 1 (invention), which is a combination of aminobutyric acid and vitamin E orotate ester, has the effect of smoothing out wrinkles, improving texture, and reducing the feeling of moisture. It appears after one month, has remarkable rapid effect and long-lasting effect, and has excellent effects. On the other hand, skin milk No. 2 (comparative example) containing only γ-aminobutyric acid has a very low effect on smoothing wrinkles and improving texture after one month, and only slightly appears after three months. . The moisturizing feeling appears a little after one month, but it is considerably lower than the skin milk No. 1 of the present invention. Also, skin milk No. 3 containing only vitamin E orotate ester (comparative example)
After one month, there is no wrinkle smoothing effect or effect on texture, and although it appears slightly after three months, it is relatively low and has a remarkable slow effect. Furthermore, a skin milk base (base) that does not contain both γ-aminobutyric acid and vitamin E orotate ester.
In Skin Milk No. 4 (control example), almost no effect on wrinkle smoothing, texture, or moisturizing feeling was observed even after 3 months. Example 2 (Cream) After stirring the required mixture of oil phase components shown in Table 6 below and the corresponding water phase component mixture at 80°C, the water phase components were uniformly added and mixed into the oil phase component. After that, each cream (sample No. 1 to No.
8) was prepared.

【表】 次に、得られた各クリーム(第6表のNo.1〜No.
8)について、前記の試験法により荒れ肌改善効
果、角質改善効果、角質層のターンオーバー速度
をしらべた。その結果を第7表に示した。
[Table] Next, each of the obtained creams (No. 1 to No. 6 in Table 6)
Regarding 8), the effect on improving rough skin, the effect on improving keratin, and the turnover rate of the stratum corneum were investigated using the test method described above. The results are shown in Table 7.

【表】【table】

【表】 第7表の結果からも明らかなように、γ−アミ
ノ酪酸系化合物とビタミンEオロチン酸エステル
を併用、配合した本発明のクリーム(No.1、No.
3、No.4、No.5、No.6)は、荒れ肌改善効果、角
質改善効果に優れ、角質層のターンオーバー速度
は極めて早く、かつこれらの諸効果は相乗的に向
上している。 更に、第6表に示す各クリームを小じわに悩み
を有する被検者(25才〜45才の女性)50名に、1
日2回(朝、夕)、連続3ケ月間塗布、使用せし
めた場合の実用テスト(パネルテスト)の結果を
第8表に示した。
[Table] As is clear from the results in Table 7, the creams of the present invention (No. 1, No.
3, No. 4, No. 5, and No. 6) are excellent in improving effects on rough skin and improving keratin, the turnover rate of the stratum corneum is extremely fast, and these effects are synergistically improved. Furthermore, 1 dose of each cream shown in Table 6 was given to 50 subjects (females aged 25 to 45) who were concerned about fine lines.
Table 8 shows the results of a practical test (panel test) when the product was applied and used twice a day (morning and evening) for three consecutive months.

【表】 第8表の結果からも明らかなように、γ−アミ
ノ酪酸系化合物とビタミンEオロチン酸エステル
とを併用、配合した本発明のクリーム(No.1、No.
3、No.4、No.5、No.6)は、しわのばし効果、き
めに対する効果、しつとり感に対する効果におい
ても著しく優れており、またそれらの諸効果は相
乗的に向上している。
[Table] As is clear from the results in Table 8, the creams of the present invention (No. 1, No.
3, No. 4, No. 5, and No. 6) are extremely superior in their wrinkle smoothing effect, texture effect, and moisturizing effect, and these effects are synergistically improved. .

Claims (1)

【特許請求の範囲】 1 下記一般式 (式中でR1、R2は水素原子またはメチル基であ
り、Rは水素原子またはアルキル基、アルケニル
基である) で表わされるγ−アミノ酪酸系化合物の少なくと
も一つとビタミンEオロチン酸エステルとを皮膚
化粧料基剤に配合してなる皮膚老化防止用化粧
料。 2 前記のγ−アミノ酪酸系化合物の少なくとも
一つが、組成物の重量に対して0.01〜25重量%配
合される特許請求の範囲第1項記載の化粧料。 3 前記のビタミンEオロチン酸エステルが、組
成物の重量に対して0.01〜25重量%配合される特
許請求の範囲第1項記載の化粧料。
[Claims] 1. The following general formula (In the formula, R 1 and R 2 are a hydrogen atom or a methyl group, and R is a hydrogen atom or an alkyl group or an alkenyl group.) and vitamin E orotate ester. A cosmetic for preventing skin aging, which is made by blending the following into a skin cosmetic base. 2. The cosmetic according to claim 1, wherein at least one of the γ-aminobutyric acid compounds is blended in an amount of 0.01 to 25% by weight based on the weight of the composition. 3. The cosmetic according to claim 1, wherein the vitamin E orotate ester is blended in an amount of 0.01 to 25% by weight based on the weight of the composition.
JP4067684A 1984-03-02 1984-03-02 Cosmetic for preventing aging of skin Granted JPS60184005A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4067684A JPS60184005A (en) 1984-03-02 1984-03-02 Cosmetic for preventing aging of skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4067684A JPS60184005A (en) 1984-03-02 1984-03-02 Cosmetic for preventing aging of skin

Publications (2)

Publication Number Publication Date
JPS60184005A JPS60184005A (en) 1985-09-19
JPS627162B2 true JPS627162B2 (en) 1987-02-16

Family

ID=12587128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4067684A Granted JPS60184005A (en) 1984-03-02 1984-03-02 Cosmetic for preventing aging of skin

Country Status (1)

Country Link
JP (1) JPS60184005A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287506A (en) * 1985-10-15 1987-04-22 Kanebo Ltd Cosmetic for preventing aging of skin
JPS63150209A (en) * 1986-12-15 1988-06-22 Kanebo Ltd Skin cosmetic
JP3256369B2 (en) * 1994-03-03 2002-02-12 カネボウ株式会社 Skin cosmetics
UA10208A (en) * 1994-08-03 1996-12-25 Жанна Прокопівна Гудзенко Dermatological cosmetic preparation
ATE228834T1 (en) * 1994-09-30 2002-12-15 Oreal USE OF A CHLORIDE CHANNEL-ASSOCIATED RECEPTOR AGONIST FOR THE TREATMENT OF SKIN WRINKLES
JPH08264272A (en) * 1995-03-27 1996-10-11 Seta Giken:Kk Electromagnetic induction heater
FR2909280B1 (en) * 2006-11-30 2015-04-17 Marcel Georges Cohen USE OF GAMMA-AMINOBUTYRIC ACID AS DEPIGMENTING AGENT
JP5297631B2 (en) * 2007-11-13 2013-09-25 花王株式会社 Skin external composition

Also Published As

Publication number Publication date
JPS60184005A (en) 1985-09-19

Similar Documents

Publication Publication Date Title
JP2003286126A (en) Oil-in-water type emulsified cosmetic
JPH08208453A (en) Cosmetic for preventing skin aging
JPS627162B2 (en)
JPH10130135A (en) Cosmetic for preventing aging of skin
JPH0686373B2 (en) Cosmetics
JP3426436B2 (en) Skin cosmetics
JPH1129457A (en) Skin cosmetic
JP2001010946A (en) Skin cosmetic
JPH11180851A (en) Skin cosmetic
JPS6281307A (en) Skin cosmetic
JP3602237B2 (en) Cleansing composition
JP2000264825A (en) Emulsion composition
JP3532713B2 (en) Skin cosmetics
JP3078051B2 (en) Anti-aging skin cosmetics
JPS6287506A (en) Cosmetic for preventing aging of skin
JPS6239511A (en) Cosmetic for preventing aging of skin
JP2995014B2 (en) Skin cosmetics
JPH07196465A (en) Skin metabolism promoter
JP3010028B2 (en) Skin cosmetics
JP2000001421A (en) Cosmetic for preventing skin aging
JPH06157276A (en) Skin external preparation
CN118045007A (en) Face cream composition and preparation method thereof
JPS5839611A (en) Dandruff-suppressing hair cosmetic
JPH0128725B2 (en)
JP3477229B2 (en) Gel composition and emulsion composition